Peer-reviewed research Insights > Peer-reviewed research Research that drives results Your strategic decisions need more than data. They need insights that translate into measurable business impact. Our peer-reviewed publications demonstrate the analytical rigor and methodological expertise we bring to every client project. When you work with consultants who contribute to the scientific foundation of the pharmaceutical industry, you benefit from research capabilities that produce findings worthy of peer review, applied directly to your business objectives. Your competitive advantage through Forskermaskine You gain a unique advantage through our authorized access to Statistics Denmark and the Danish Health Data Authority’s “Forskermaskine”. This official validation of our research capabilities means you can leverage microdata and analytical approaches that strengthen your market position. Your projects benefit from evidence-based insights that support your strategy and help you demonstrate your product’s value in real-world settings. Ready to discuss your next research project? When you need research that drives business performance and supports strategic decision-making, you work with the same team that produces peer-reviewed publications. We combine academic rigor with commercial expertise to deliver research that drives measurable business outcomes. Browse our case studies to see how we’ve supported companies with similar challenges. Explore research opportunities Recent publications Below you’ll find a selection of our recent peer-reviewed publications. This represents just a portion of our ongoing research activities. Our team regularly contributes to academic journals and collaborates with universities and authorities to advance pharmaceutical and healthcare knowledge. Drug survival and risk factors for ADHD medication discontinuation in adults: A Danish Nationwide Registry-based cohort study Pelle Lau Ishøy, Kim Berg Engersgaard Johannessen, Tine Houmann, Eline Levin, Per Hove Thomsen Read the publication Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark – an observational registry study of 30 100 Danish patients with glaucoma Andreas Høiberg Bentsen, Rikke Færgemann Hansen, Anne Cathrine Falch-Jørgensen, Louise G Dal, Emma Sabelstrøm, Magnus Brandel, Miriam Kolko Read the publication Real-world impact of once-weekly subcutaneous semaglutide after 2 years of follow-up: Results from a nationwide observational study in people with type 2 diabetes Tina Vilsbøll, Caroline Ø. Lindahl, Nick F. Nielsen, Christian K. Tikkanen Read the publication Kill your darlings: Stop using the terms retrospective and prospective Mikkel Zöllner Ankarfeldt, Benedikte Irene Von Osmanski, Kim Blond Read the publication The analogue substitution model: Introducing competition in the absence of generic substitution in Danish hospitals Elisabeth Christensen, Niels Christian Hirsch, Jonas Valbjørn Andersen, Lars Holger Ehlers Read the publication Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research Charlotte Thor Petersen, Kristoffer Jarlov Jensen, Mary Rosenzweig, Benedikte Irene von Osmanski, Mikkel Zöllner Ankarfeldt, Janne Petersen Read the publication Drug survival and risk factors for ADHD medication discontinuation in adults: A Danish Nationwide Registry-based cohort study Pelle Lau Ishøy, Kim Berg Engersgaard Johannessen, Tine Houmann, Eline Levin, Per Hove Thomsen Read the publication For more information, please contact Anne Cathrine Falch-Jørgensen Head of Real-World Evidence Denmark, Team Lead acfj@signumlifescience.com +45 61 776 975 Get in touch Leave a message and we will get back to you ASAP. Your personal information will be processed according to our Privacy Policy. First Name: Last Name: Company: E-mail: Your Message:
